Q3 FY2026 · ended Sep 30, 2026 · Revenue $371.07M, -1.7% YoY · Filed Nov 5, 2026
Guardian Pharmacy Services, Inc. (GRDN) files with the SEC under industry code 5912, Retail-Drug Stores and Proprietary Stores. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $371.1 million and net income of $18.7 million. As of Sep 30, 2026 it held $119.7 million in cash and investments and $35.6 million in total debt.
Revenue
$371.07M
-1.7% vs year-ago quarter
Net income
$18.68M
+90.3% vs year-ago quarter
Operating cash flow
$43.37M
+54.0% vs year-ago quarter
Free cash flow
$30.02M
+172.6% vs year-ago quarter
EPS
$0.29
Dividend per share
None
Shares outstanding
—
Net cash
$84.06M
Q3 FY2026
Operating margin
6.5%
TTM
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- GRDN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- GA
- Headquarters
- Atlanta, GA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1802255
- Former names
- Guardian Pharmacy Services, Inc. (until Nov 5, 2026); Guardian Pharmacy, LLC (until Jul 23, 2021)
Other Retail-Drug Stores and Proprietary Stores companies
- CVS HEALTH Corp CVS
- 111, Inc. YI
- Petmed Express Inc PETS
- Ridgetech Inc. RDGT
- TREES Corp (Colorado) CANN
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $371.1M | $351.8M | $336.6M | $397.6M | $377.4M |
| Operating income | $25.1M | $20.6M | $17.7M | $30.8M | $16.4M |
| Net income | $18.7M | $21.9M | $13.3M | $20.9M | $9.8M |
| Diluted EPS | $0.29 | — | — | — | — |
| Operating cash flow | $43.4M | $30.0M | $6.1M | $34.6M | $28.2M |
| Free cash flow | — | $30.0M | — | $34.1M | $24.2M |
| Total assets | $491.8M | $443.6M | $426.9M | $412.7M | $390.0M |
| Total liabilities | $212.1M | $185.9M | $194.5M | $194.7M | $194.5M |
| Stockholders' equity | $279.7M | $257.6M | $232.4M | $217.9M | $195.5M |
| Cash and investments | $119.7M | $89.8M | $64.9M | $65.6M | $36.5M |
| Total debt | $35.6M | $35.2M | $36.9M | $44.7M | $34.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 22, 2026 | Jun 22, 2026 |
All 226 Guardian Pharmacy Services, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.